Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series

Haematologica. 2016 May;101(5):e182-4. doi: 10.3324/haematol.2015.139691. Epub 2016 Jan 27.
No abstract available

Keywords: essential thrombocythemia; outcomes; pegylated interferon; pregnancy; safety.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / adverse effects
  • Polyethylene Glycols / administration & dosage*
  • Polyethylene Glycols / adverse effects
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood
  • Pregnancy Complications, Hematologic / drug therapy*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Thrombocythemia, Essential / blood
  • Thrombocythemia, Essential / drug therapy*

Substances

  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a